51 related articles for article (PubMed ID: 36319794)
1. Clinically Driven Alpha/Beta Ratios for Melanoma Brain Metastases and Investigation of Biologically Effective Dose as a Predictor for Local Control After Radiosurgery: A Proof of Concept in a Retrospective Longitudinal Series of 274 Consecutive Lesions.
Zubatkina I; Toma-Dasu I; Dasu A; Levivier M; Tuleasca C; Ivanov P
Neurosurgery; 2024 Feb; 94(2):423-430. PubMed ID: 37665222
[TBL] [Abstract][Full Text] [Related]
2. Integrated Assessment of Circulating Cell-Free MicroRNA Signatures in Plasma of Patients with Melanoma Brain Metastasis.
Bustos MA; Tran KD; Rahimzadeh N; Gross R; Lin SY; Shoji Y; Murakami T; Boley CL; Tran LT; Cole H; Kelly DF; O'Day S; Hoon DSB
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32630542
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
Persson O; Bartek J; Shalom NB; Wangerid T; Jakola AS; Förander P
Acta Neurochir (Wien); 2017 Jun; 159(6):1013-1021. PubMed ID: 28409393
[TBL] [Abstract][Full Text] [Related]
4. Radiosurgery fractionation and post-treatment hemorrhage development for intact melanoma brain metastases.
McKenzie G; Gaskins J; Rattani A; Oliver A; Southall W; Nakamura F; Yusuf M; Mistry A; Williams B; Woo S
J Neurooncol; 2022 Dec; 160(3):591-599. PubMed ID: 36319794
[TBL] [Abstract][Full Text] [Related]
5. Toxicity and outcomes of melanoma brain metastases treated with stereotactic radiosurgery: the risk of subsequent symptomatic intralesional hemorrhage exceeds that of radiation necrosis.
Jablonska PA; Muniz T; Ribeiro M; Liu ZA; Ye XY; Devaraja K; Laperriere N; Millar BA; Conrad T; Kongkham P; Butler M; Shultz DB
J Neurooncol; 2023 Aug; 164(1):199-209. PubMed ID: 37552363
[TBL] [Abstract][Full Text] [Related]
6. Single-dose versus fractionated stereotactic radiotherapy for brain metastases.
Kim YJ; Cho KH; Kim JY; Lim YK; Min HS; Lee SH; Kim HJ; Gwak HS; Yoo H; Lee SH
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):483-9. PubMed ID: 20800386
[TBL] [Abstract][Full Text] [Related]
7. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiosurgery for melanoma brain metastases: dose-size response relationship in the era of immunotherapy.
Yusuf M; Rattani A; Gaskins J; Oliver AL; Mandish SF; Burton E; May ME; Williams B; Ding D; Sharma M; Miller D; Woo S
J Neurooncol; 2022 Jan; 156(1):163-172. PubMed ID: 34807342
[TBL] [Abstract][Full Text] [Related]
9. MRI characteristics in treatment for cerebral melanoma metastasis using stereotactic radiosurgery and concomitant checkpoint inhibitors or targeted therapeutics.
Rauch M; Tausch D; Stera S; Blanck O; Wolff R; Meissner M; Urban H; Hattingen E
J Neurooncol; 2021 May; 153(1):79-87. PubMed ID: 33761055
[TBL] [Abstract][Full Text] [Related]
10. Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies.
Bander ED; Yuan M; Carnevale JA; Reiner AS; Panageas KS; Postow MA; Tabar V; Moss NS
Cancer; 2021 Jun; 127(12):2062-2073. PubMed ID: 33651913
[TBL] [Abstract][Full Text] [Related]
11. Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases.
Trembath DG; Davis ES; Rao S; Bradler E; Saada AF; Midkiff BR; Snavely AC; Ewend MG; Collichio FA; Lee CB; Karachaliou GS; Ayvali F; Ollila DW; Krauze MT; Kirkwood JM; Vincent BG; Nikolaishvilli-Feinberg N; Moschos SJ
Front Oncol; 2020; 10():604213. PubMed ID: 33552976
[TBL] [Abstract][Full Text] [Related]
12. Tumor Control Probability of Radiosurgery and Fractionated Stereotactic Radiosurgery for Brain Metastases.
Redmond KJ; Gui C; Benedict S; Milano MT; Grimm J; Vargo JA; Soltys SG; Yorke E; Jackson A; El Naqa I; Marks LB; Xue J; Heron DE; Kleinberg LR
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):53-67. PubMed ID: 33390244
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
